Active IgGκ Multiple Myeloma Presenting With Crystalline Keratopathy.
作者信息
Turnbull Andrew M J, Karmiris Efthymios, Anderson David F
机构信息
Department of Ophthalmology, University Hospital Southampton, Southampton, England.
出版信息
JAMA Ophthalmol. 2018 Jul 12;136(7):e181505. doi: 10.1001/jamaophthalmol.2018.1505.
Abstract
摘要
相似文献
1
Active IgGκ Multiple Myeloma Presenting With Crystalline Keratopathy.伴有结晶性角膜病变的活动性IgGκ多发性骨髓瘤
JAMA Ophthalmol. 2018 Jul 12;136(7):e181505. doi: 10.1001/jamaophthalmol.2018.1505.
2
Paraproteinemic Maculopathy in a 63-Year-Old Man.
JAMA Ophthalmol. 2018 Aug 1;136(8):944-945. doi: 10.1001/jamaophthalmol.2017.6285.
3
Vanishing corneal epithelial crystals following thalidomide induced resolution of myeloma related paraproteinaemia.沙利度胺诱导骨髓瘤相关副蛋白血症消退后角膜上皮晶体消失
Br J Ophthalmol. 2002 Nov;86(11):1315-6. doi: 10.1136/bjo.86.11.1315.
4
Case report of coexistence of myeloproliferative neoplasms and multiple myeloma.骨髓增殖性肿瘤与多发性骨髓瘤并存的病例报告。
Kaohsiung J Med Sci. 2020 Jun;36(6):469-470. doi: 10.1002/kjm2.12186. Epub 2020 Jan 31.
5
Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.硼替佐米与地塞米松成功治疗多发性骨髓瘤伴单克隆IgG沉积的增殖性肾小球肾炎：一例报告
BMC Nephrol. 2017 Apr 6;18(1):127. doi: 10.1186/s12882-017-0524-7.
6
The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma.低剂量沙利度胺联合硼替佐米及地塞米松治疗难治性多发性骨髓瘤
Intern Med. 2016;55(20):3025-3028. doi: 10.2169/internalmedicine.55.6470. Epub 2016 Oct 15.
7
Thalidomide and low-dose dexamethasone in myeloma treatment.沙利度胺与小剂量地塞米松用于骨髓瘤治疗
Br J Haematol. 2001 Jul;114(1):245. doi: 10.1046/j.1365-2141.2001.02873-5.x.
8
Paraproteinemic Keratopathy: The Expanding Diversity of Clinical and Pathologic Manifestations.副蛋白血症性角膜病变：临床表现和病理表现多样性的不断扩大。
Ophthalmology. 2015 Sep;122(9):1748-56. doi: 10.1016/j.ophtha.2015.05.029. Epub 2015 Jun 26.
9
Simmering Below the Surface: Sweet's Syndrome with Multiple Myeloma.表面之下的隐匿：伴多发性骨髓瘤的斯韦特综合征
Am J Med. 2018 Sep;131(9):1058-1060. doi: 10.1016/j.amjmed.2018.04.014. Epub 2018 May 2.
10
[Crystalline keratopathy as a presenting sign of multiple myeloma].
Klin Monbl Augenheilkd. 1999 Jun;214(6):412-4. doi: 10.1055/s-2008-1034822.
引用本文的文献
1
Exploring the ocular involvement in multiple myeloma: a comprehensive review of 70-year clinical studies.探索多发性骨髓瘤的眼部受累：70年临床研究的综合综述
Int Ophthalmol. 2025 Mar 14;45(1):89. doi: 10.1007/s10792-025-03467-9.
Zotero 插件